Mayo Clinic Researchers Report New Strategy to Strengthen CAR-T Therapy in Thyroid Cancer
Mayo Clinic researchers report a new strategy that may help CAR-T therapy work better against thyroid cancer.
New scientific findings on the causes, detection and treatment of cancer.
Protein-Proximity Therapies Gain Momentum in Cancer Research
Protein-proximity therapies are advancing after the first approved PROTAC for breast cancer, signaling a new phase in precision medicine.
A personalised cancer vaccine marks a possible turning point for melanoma care
A personalised mRNA melanoma vaccine shows success in a late-stage trial, boosting hopes for bespoke cancer therapies.
AI-Assisted Brain Tumour Surgery Shows Early Promise for UK Patients
AI-assisted brain tumour surgery has shown early promise in the UK, with a reported sight-saving outcome for one patient.
Manchester Team Identifies Immune Cells That Could Strengthen Cancer Immunotherapy
Researchers identify activated dendritic cells as key to anti-cancer immunity, opening new possibilities for immunotherapy.
Mayo Clinic Researchers Estimate Pancreatic Cyst Cancer Risk in New Study
Mayo Clinic researchers estimate pancreatic cyst cancer risk, helping guide earlier detection and more personalized surveillance.
NHS Eyes Precision Radiotherapy Rollout as UK Cancer Care Moves Faster and Further
England is rolling out precision radiotherapy for prostate cancer, cutting treatment sessions from 20 to five.
Engineered CAR T Cells Show Promise Against Bladder Cancer in Preclinical Study
Engineered CAR T cells controlled bladder tumors in mice, offering a potential new bladder cancer treatment route.
NICE Recommends First New NHS Treatment in Two Decades for Resistant Ovarian Cancer
NICE recommends Elahere for resistant ovarian cancer, offering the first new NHS treatment in over 20 years.
